Rodriguez lab, Translational Therapeutics of Stanford University, Stanford School of Medicine, is currently looking for participants with Obsessive Compulsive Disorder, ages 18 – 65 years for their research on “Examining Mu Opioid Mechanisms of Ketamine’s Rapid Effects in Obsessive Compulsive Disorder”.
After more than 70 years of antipsychotic medications that are mere iterations of earlier discoveries, a door may have cracked open to offer better options for individuals struggling with severe mental illness. There is much more research to be done, said Dr. Jacob Ballon, who specializes in the treatment of individuals with psychotic disorders including schizophrenia and is Co-Director of the INSPIRE Clinic at Stanford.
Dr. Katherine Taylor is our June 11 “Ask the Doctor” general meeting presenter. Before she delves into your questions, Dr. Taylor will review recent trends in acute psychiatry being seen at El Camino Hospital. She will discuss the importance of awareness and education regarding the potential mental health risks associated with cannabis and methamphetamine use.…
“In Our Own Voice” is a unique public education program developed by NAMI, in which two trained consumer speakers share compelling and personal testimonies of living with and overcoming the challenges posed by mental illness. Audience participation and discussion are encouraged, and a brief video with a variety of stories accompanies the presentation.
The Ending the Silence (ETS) presenter’s purpose is to inform high school students of the symptoms and indicators of mental illness as well as explore ways for people to help themselves, friends or family members who may be in need of support.